Confirmed Sponsors

With thanks to our Sponsors

Principal Partner

Xstrahl is a pioneer in the development of pre-clinical X–ray research solutions designed to deliver radiation doses to in vivo and in vitro biological specimens. Xstrahl’s advanced research systems include the SARRP (Small Animal Radiation Research Platform), the most advanced commercially available 3D image-guided micro irradiator. Headquartered in the UK with manufacturing facilities both in the UK and USA, Xstrahl operates globally through its international network of distributors.

Associate Partner

Varian, of Palo Alto, California, is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian employs over 7,000 people, located at manufacturing sites, sales and support offices worldwide (

Bio coming soon…

Poster Prize Sponsor


Bio coming soon…

Speaker Sponsor

Cancer Research UK is the largest independent funder of cancer research in Europe and the world’s leading charity dedicated to cancer research. We pioneer research to bring forward the day when all cancers are cured. Our ambition is to accelerate progress so that we see three quarters of people survive cancer within 20 years.

Lanyard Sponsor

Lovelace Biomedical is a contract research organization with over 60 years of experience in radiation dosimetry, biomarkers and animal model development.  Our facility was founded by the Atomic Energy Commission, later the Department of Energy, to improve our understanding of human health response to external radiation and radionuclides.  Today we have built on that legacy to expand our capabilities in animal models, pharmacology and drug development.

Exhibiting Companies


Taylor & Francis is a leading publisher of scholarly journals, books, eBooks, text books and reference works in all areas of the Humanities, Social Sciences, Behavioural Sciences, Science, Technology and Medicine sectors. We publish Medicine & Health journal articles under the imprints Taylor & Francis, Cogent OA, and Dove Medical Press. We are proud to present the Kaplan Award at this year’s ICRR Conference.

If your work involves the culture of cells and you need strict, accurate control over O2, CO2, temperature and humidity, visit the Don Whitley Scientific stand. The Hypoxystation range of workstations has been developed specifically for cancer researchers and provides a range of features to help replicate the tumour microenvironment.

Originally developed by Augmenix, SpaceOAR™ Hydrogel is now part of the Boston Scientific portfolio. SpaceOAR® hydrogel, the company’s lead product, is a soft, absorbable gel spacer that pushes the rectum away from the prostate in men undergoing prostate radiotherapy, reducing rectal dose and injury to the rectum and surrounding tissues. To date, over 30,000 patients worldwide have benefitted from the SpaceOAR hydrogel procedure. More information be found at

Bio coming soon…

Alpha Tau Medical focuses on R&D and commercialization of the first alpha-radiation-based cancer treatment for solid tumors, the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).


Alpha DaRT has several important advantages:

  • Highly potent and conformal
  • Low local toxicity, no negative systemic effects
  • Enhances anti-tumor immune response
  • Effective regardless of tumor oxygen level
  • Short half-life – quick clinical outcome
  • Disposable applicators – does not require capital equipment or special shielding

Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. Our Radiation Biology program is supported by an experienced team of scientists and technicians who use the latest clinical-grade equipment and biomarkers to perform non-GLP efficacy and GLP pivotal studies under the FDA ‘Animal Rule.’